Serotonergic and Cholinergic Strategies as Potential Targets for the Treatment of Schizophrenia

E-ISSN： 1873-4286|22|14|2093-2116

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.14, 2016-04, pp. : 2093-2116

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treating Schizophrenia: Novel Targets for the Cholinergic System

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 2, 2010-04 ,pp. : 241-256

Bentham Science Publishers

Access to resources Recommend Favorite

Potential therapeutic targets for schizophrenia

By Wong A.H. Sanyal S. Knapp M.G. van Tol H.H.

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 4, 1999-12 ,pp. : 571-586

Informa Healthcare

Access to resources Recommend Favorite

Metabotropic Glutamate Receptors: Potential Drug Targets for the Treatment of Schizophrenia

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 3, 2002-06 ,pp. : 261-281

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Treatment Strategies and Potential Therapeutic Targets in Primary Sjogren's Syndrome

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 9, Iss. 1, 2010-03 ,pp. : 10-19

Bentham Science Publishers

Access to resources Recommend Favorite

Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists

By Friedman Joseph

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 45-53

Springer Publishing Company

Access to resources Recommend Favorite